Coronavirus: ‘Encouraging’ results for drug, India joins trials
NEW DELHI: India is part of the WHO ‘solidarity trials’ for the drug Remdesivir, which has shown encouraging results in serious Covid-19 patients needing enhanced oxygen and ventilator support, and will be able to access any benefits that accrue from the anti-viral medication once it is established for clinical use. Tests were carried out with Remdesivir, developed for use against Ebola.
The tests showed significant benefits for two-thirds patients with severe symptoms during use on a set of patients in the US, Canada, Europe and Japan, said Dr Raman Gangakhedkar of Indian Council of Medical Research at the health ministry briefing on Monday. The tests, he clarified, were not clinical trials.
The drug was able to help about two-thirds of the patients to get off oxygen and ventilator support, he said.
The tests showed significant benefits for two-thirds patients with severe symptoms during use on a set of patients in the US, Canada, Europe and Japan, said Dr Raman Gangakhedkar of Indian Council of Medical Research at the health ministry briefing on Monday. The tests, he clarified, were not clinical trials.
The drug was able to help about two-thirds of the patients to get off oxygen and ventilator support, he said.
No comments: